Kathleen Ludwig, M.D.

Harold C. Simmons Comprehensive Cancer Center

Pediatrics - Hematology-Oncology
Pediatric Hematology/Oncology

Biography

Kathleen Ludwig, M.D., is an Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center. She specializes in pediatric hematology and oncology.

Dr. Ludwig earned her medical degree at the Loyola University Chicago Stritch School of Medicine. She completed her residency in pediatrics at UT Southwestern, where she also received advanced training through a fellowship in pediatric hematology and oncology.

Certified by the American Board of Pediatrics, she joined the UT Southwestern faculty in 2015.

Dr. Ludwig’s clinical and research interests include leukemia and vascular anomalies. She is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Society of Pediatric Hematology/Oncology, and the Children’s Oncology Group.

Education & Training

Medical School - Loyola University Chicago Stritch School of Medicine (2005-2009)
Residency - UT Southwestern/Children's Medical Center (2009-2012), Pediatrics
Fellowship - UT Southwestern/Children's Medical Center (2012-2015), Pediatric Hematology/oncology

Professional Associations & Affiliations

American Society of Clinical Oncology
American Society of Hematology
American Society of Pediatric Hematology/Oncology
Children’s Oncology Group

Honors & Awards

D Magazine Best Doctor 2022
D Magazine Best Pediatric Specialist 2021
Best Basic Science Award 2014, Annual Surgical Research Forum, UT Southwestern
Best Poster Award 2015, UT Southwestern Pediatric Fellow's Research Symposium
Above-and-Beyond Recognition for Excellence 2010, UT Southwestern Pediatric Residency Program

Books & Publications

Publications
- Response to Alpelisib in Clinically Distinct Pediatric Patients With PIK3CA-related Disorders.
  Kolitz E, Fernandes NJ, Agim NG, Ludwigl K, Journal of pediatric hematology/oncology 2022 Feb
- Recent progress in the treatment of cancer in children.
  Butler E, Ludwig K, Pacenta HL, Klesse LJ, Watt TC, Laetsch TW, CA: a cancer journal for clinicians 2021 Apr
- Giant Congenital Melanocytic Nevus Treated With Trametinib.
  Mir A, Agim NG, Kane AA, Josephs SC, Park JY, Ludwig K Pediatrics 2019 Feb
- Small molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer.
  Ludwig KF, Du W, Sorrelle N, Wnuk-Lipinska K, Topalovski M, Toombs JE, Cruz VH, Yabuuchi S, Rajeshkumar NV, Maitra A, Lorens JB, Brekken RA Cancer research 2017 Nov
- A New Case and Review of Chylothorax in Generalized Lymphatic Anomaly and Gorham-Stout Disease.
  Ludwig KF, Slone T, Cederberg KB, Silva AT, Dellinger M Lymphology 2016 Jun 49 2 73-84
- Warfarin blocks Gas6-mediated Axl activation required for pancreatic cancer epithelial plasticity and metastasis.
  Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, Toombs JE, Wang M, Dineen SP, Micklem D, Dellinger MT, Lorens JB, Brekken RA Cancer research 2015 Jul

Research

Leukemia
Vascular Anomalies

Clinical Focus

Pediatric Hematology/Oncology

Links

New Patient Appointment